Deficiency in IL-1 receptor type 2 aggravates K/BxN serum transfer-induced arthritis in mice but has no impact on systemic inflammatory responses

Journal of Immunology

Volumn 198, Issue 7, 2017, Pages 2916-2926

  Martin, Praxedis ^a,b   Palmer, Gaby ^a,b   Rodriguez, Emiliana ^a,b   Seemayer, Christian Alexander ^c   Palomo, Jennifer ^a,b   Talabot Ayer, Dominique ^a,b   Gabay, Cem ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FIBROBLAST; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; WILD TYPE MOUSE; ANIMAL; EXPERIMENTAL ARTHRITIS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KNOCKOUT MOUSE; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-1 TYPE II;

EID: 85016264219     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600855     Document Type: Article

References (42)

1. Palomo, J., D. Dietrich, P. Martin, G. Palmer, and C. Gabay. 2015. The interleukin (IL)-1 cytokine family-balance between agonists and antagonists in inflammatory diseases. Cytokine 76: 25-37.
2. Gabay, C., C. Lamacchia, and G. Palmer. 2010. IL-1 pathways in inflammation and human diseases. Nat. Rev. Rheumatol. 6: 232-241.
3. Arend, W. P., M. Malyak, C. J. Guthridge, and C. Gabay. 1998. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16: 27-55.
4. McMahan, C. J., J. L. Slack, B. Mosley, D. Cosman, S. D. Lupton, L. L. Brunton, C. E. Grubin, J. M. Wignall, N. A. Jenkins, C. I. Brannan, et al. 1991. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10: 2821-2832.
5. Colotta, F., S. K. Dower, J. E. Sims, and A. Mantovani. 1994. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Immunol. Today 15: 562-566.
6. Burger, D., R. Chicheportiche, J. G. Giri, and J. M. Dayer. 1995. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J. Clin. Invest. 96: 38-41.
7. Martin, P., G. Palmer, S. Vigne, C. Lamacchia, E. Rodriguez, D. Talabot-Ayer, S. Rose-John, A. Chalaris, and C. Gabay. 2013. Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions. J. Leukoc. Biol. 94: 791-802.
8. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giri, S. K. Dower, J. E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472-475.
9. Colotta, F., S. Saccani, J. G. Giri, S. K. Dower, J. E. Sims, M. Introna, and A. Mantovani. 1996. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 156: 2534-2541.
10. Giri, J. G. J., J. Wells, S. K. Dower, C. E. McCall, R. N. Guzman, J. Slack, T. A. Bird, K. Shanebeck, K. H. Grabstein, J. E. Sims, et al. 1994. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153: 5802-5809.
11. Colotta, F., S. Orlando, E. J. Fadlon, S. Sozzani, C. Matteucci, and A. Mantovani. 1995. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J. Exp. Med. 181: 2181-2186.
12. Orlando, S., C. Matteucci, E. J. Fadlon, W. A. Buurman, M. T. Bardella, F. Colotta, M. Introna, and A. Mantovani. 1997. TNF-alpha, unlike other proand anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells. J. Immunol. 158: 3861-3868.
13. Pettipher, E. R., G. A. Higgs, and B. Henderson. 1986. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. USA 83: 8749-8753.
14. Iwakura, Y. 2002. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine Growth Factor Rev. 13: 341-355.
15. Joosten, L. A., M. M. Helsen, F. A. van de Loo, and W. B. van den Berg. 1996. Anticytokine treatment of established type II collagen-induced arthritis in DBA/ 1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum. 39: 797-809.
16. van den Berg, W. B., L. A. Joosten, M. Helsen, and F. A. van de Loo. 1994. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95: 237-243.
17. Dawson, J., P. Engelhardt, T. Kastelic, D. Cheneval, A. MacKenzie, and P. Ramage. 1999. Effects of soluble interleukin-1 type II receptor on rabbit antigen-induced arthritis: clinical, biochemical and histological assessment. Rheumatology (Oxford) 38: 401-406.
18. Jacques, C., M. Gosset, F. Berenbaum, and C. Gabay. 2006. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam. Horm. 74: 371-403.
19. Dinarello, C. A., A. Simon, and J. W. van der Meer. 2012. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11: 633-652.
20. Bessis, N., L. Guéry, A. Mantovani, A. Vecchi, J. E. Sims, D. Fradelizi, and M. C. Boissier. 2000. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Eur. J. Immunol. 30: 867-875.
21. Shimizu, K., A. Nakajima, K. Sudo, Y. Liu, A. Mizoroki, T. Ikarashi, R. Horai, S. Kakuta, T. Watanabe, and Y. Iwakura. 2015. IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages. J. Immunol. 194: 3156-3168.
22. Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23: 5080-5081.
23. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277.
24. Martin, P., D. Talabot-Ayer, C. A. Seemayer, S. Vigne, C. Lamacchia, E. Rodriguez, A. Finckh, D. E. Smith, C. Gabay, and G. Palmer. 2013. Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency. Arthritis Res. Ther. 15: R13.
25. Chou, R. C., N. D. Kim, C. D. Sadik, E. Seung, Y. Lan, M. H. Byrne, B. Haribabu, Y. Iwakura, and A. D. Luster. 2010. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity 33: 266-278.
26. Lamacchia, C., E. Rodriguez, G. Palmer, S. Vigne, P. Martin, D. Talabot-Ayer, C. A. Seemayer, and C. Gabay. 2012. Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice. Ann. Rheum. Dis. 71: 281-287.
27. Daun, J. M., R. W. Ball, H. R. Burger, and J. G. Cannon. 1999. Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in vivo. J. Leukoc. Biol. 65: 863-866.
28. Lamacchia, C., G. Palmer, L. Bischoff, E. Rodriguez, D. Talabot-Ayer, and C. Gabay. 2010. Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice. J. Immunol. 185: 2516-2524.
29. Hirsch, E., V. M. Irikura, S. M. Paul, and D. Hirsh. 1996. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc. Natl. Acad. Sci. USA 93: 11008-11013.
30. Rauschmayr, T., R. W. Groves, and T. S. Kupper. 1997. Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation. Proc. Natl. Acad. Sci. USA 94: 5814-5819.
31. Mantovani, A., M. A. Cassatella, C. Costantini, and S. Jaillon. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11: 519-531.
32. Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13: 159-175.
33. Wipke, B. T., and P. M. Allen. 2001. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 167: 1601-1608.
34. Cross, M., I. Mangelsdorf, A. Wedel, and R. Renkawitz. 1988. Mouse lysozyme M gene: isolation, characterization, and expression studies. Proc. Natl. Acad. Sci. USA 85: 6232-6236.
35. Ji, H., A. Pettit, K. Ohmura, A. Ortiz-Lopez, V. Duchatelle, C. Degott, E. Gravallese, D. Mathis, and C. Benoist. 2002. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J. Exp. Med. 196: 77-85.
36. Sims, J. E., M. A. Gayle, J. L. Slack, M. R. Alderson, T. A. Bird, J. G. Giri, F. Colotta, F. Re, A. Mantovani, K. Shanebeck, et al. 1993. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90: 6155-6159.
37. Altstaedt, J., H. Kirchner, and L. Rink. 1996. Cytokine production of neutrophils is limited to interleukin-8. Immunology 89: 563-568.
38. Oishi, K., and K. Machida. 1997. Some plasma component is essential for IL-6 secretion by Neutrophils. Environ. Health Prev. Med. 2: 89-92.
39. Reddy, P., J. L. Slack, R. Davis, D. P. Cerretti, C. J. Kozlosky, R. A. Blanton, D. Shows, J. J. Peschon, and R. A. Black. 2000. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 275: 14608-14614.
40. Cui, X., F. N. Rouhani, F. Hawari, and S. J. Levine. 2003. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J. Immunol. 171: 6814-6819.
41. Kuhn, P. H., E. Marjaux, A. Imhof, B. De Strooper, C. Haass, and S. F. Lichtenthaler. 2007. Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase. J. Biol. Chem. 282: 11982-11995.
42. Arend, W. P., M. Malyak, M. F. Smith, Jr., T. D. Whisenand, J. L. Slack, J. E. Sims, J. G. Giri, and S. K. Dower. 1994. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J. Immunol. 153: 4766-4774.